|Description||Nanotechnology for Medical Devices.|
|Seed, 2/2013 |
|Grant, 6/2013 ||$250k|
Nasseo, Inc. (“Nasseo”) is a medical device company that has developed next generation nanotube implant surface technology (“TiArray™”) that provides clinicians and patients with better dental and orthopedic implant treatment options. Nasseo’s TiArray™ nanotechnology alters the natural oxide layer of the implant material (Ti, Ta, Zi, CoCr, etc) to create a uniformed nanotube array surface that has shown stronger bonding, faster healing, anti-inflammatory, anti-bacterial, and soft tissue response benefits in over 10 years of pre-clinical R&D at UCSD. Nasseo’s first product, the TiArray™ Dental Implant, has received FDA approval and post-market human clinical trials will be conducted in 2014. Nasseo is also developing a second product which is a Titanium-PEEK hybrid interbody fusion device (spinal cage implant) that also integrates TiArray™ nanotechnology.